Palisade Bio (PALI) Retained Earnings (2010 - 2026)
Palisade Bio (PALI) reported Retained Earnings of -$162.3 million for Q1 2026, down 17.48% year-over-year from -$196.7 million in Q1 2025, and down 6.29% on a QoQ basis from -$152.7 million in Q4 2025.
Palisade Bio (PALI) has 17 years of Retained Earnings data on file, last reported at -$162.3 million in Q1 2026.
- Quarterly Retained Earnings fell 17.48% year-over-year to -$162.3 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was -$162.3 million (down 17.48% YoY) and the FY2025 annual result came in at -$152.7 million, down 12.34% from the prior year.
- Retained Earnings declined to -$162.3 million in Q1 2026 per PALI's latest filing, from -$152.7 million in the prior quarter.
- Across five years, Retained Earnings topped out at -$98.8 million in Q1 2022 and bottomed at -$162.3 million in Q1 2026.
- The 5-year median for Retained Earnings is -$125.0 million (2024), against an average of -$126.0 million.
- Peak annual rise in Retained Earnings reached 2.52% in 2022, while the deepest fall reached 3560670.89% in 2022.
- Tracing PALI's Retained Earnings over 5 years: stood at -$109.2 million in 2022, then fell by 11.28% to -$121.5 million in 2023, then retreated by 11.88% to -$135.9 million in 2024, then retreated by 12.34% to -$152.7 million in 2025, then dropped by 6.29% to -$162.3 million in 2026.
- Per Business Quant, the three latest PALI Retained Earnings figures stand at -$162.3 million (Q1 2026), -$152.7 million (Q4 2025), and -$143.8 million (Q3 2025).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Retained Earnings (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - | -211.85 Mn |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - | -153.89 Mn |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn | 1.00 Bn |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - | -438.66 Mn |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - | -279.00 Mn |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn | 14.59 Bn |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - | 130.89 Mn |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn | 36.42 Bn |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn | -24.89 Mn |
| 10 | Palisade Bio | 439.25 Mn | 309.68 Mn | - | -162.33 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -162.33 Mn |
| Dec 31, 2025 | -152.73 Mn |
| Sep 30, 2025 | -143.83 Mn |
| Jun 30, 2025 | -140.96 Mn |
| Mar 31, 2025 | -138.17 Mn |
| Dec 31, 2024 | -135.94 Mn |
| Sep 30, 2024 | -132.60 Mn |
| Jun 30, 2024 | -129.11 Mn |
| Mar 31, 2024 | -125.03 Mn |
| Dec 31, 2023 | -121.51 Mn |
| Sep 30, 2023 | -118.54 Mn |
| Jun 30, 2023 | -114.92 Mn |
| Mar 31, 2023 | -111.53 Mn |
| Dec 31, 2022 | -109.19 Mn |
| Sep 30, 2022 | -105.18 Mn |
| Jun 30, 2022 | -101.19 Mn |
| Mar 31, 2022 | -98.85 Mn |
| Dec 31, 2021 | -94.64 Mn |
| Sep 30, 2021 | -95.72 Mn |
| Jun 30, 2021 | -103.80 Mn |
| Mar 31, 2021 | -2,776.00 |
| Dec 31, 2020 | -68.03 Mn |
| Sep 30, 2020 | -3,986.00 |
| Jun 30, 2020 | -7,166.00 |
| Mar 31, 2020 | -7,148.00 |
| Dec 31, 2019 | -6,186.00 |
| Sep 30, 2019 | -7,670.00 |
| Jun 30, 2019 | -3,169.00 |
| Mar 31, 2019 | -216.74 Mn |
| Dec 31, 2018 | -213.62 Mn |
| Sep 30, 2018 | -213.30 Mn |
| Jun 30, 2018 | 1,142.00 |
| Mar 31, 2018 | 2,746.00 |
| Dec 31, 2017 | -208.70 Mn |
| Sep 30, 2017 | 2,345.00 |
| Jun 30, 2017 | 3,350.00 |
| Mar 31, 2017 | -200.60 Mn |
| Dec 31, 2016 | 3,905.00 |
| Sep 30, 2016 | -187.64 Mn |
| Jun 30, 2016 | -182.42 Mn |
| Mar 31, 2016 | 1,298.00 |
| Dec 31, 2015 | -171.96 Mn |
| Sep 30, 2015 | 3,720.00 |
| Jun 30, 2015 | -161.56 Mn |
| Mar 31, 2015 | 6,013.00 |
| Dec 31, 2014 | -151.05 Mn |
| Sep 30, 2014 | -145.55 Mn |
| Jun 30, 2014 | -141.10 Mn |
| Mar 31, 2014 | 5,977.00 |
| Dec 31, 2013 | -128.43 Mn |
| Sep 30, 2013 | -125.12 Mn |
| Jun 30, 2013 | -118.44 Mn |
| Mar 31, 2013 | -112.18 Mn |
| Dec 31, 2012 | -108.59 Mn |
| Sep 30, 2012 | -105.88 Mn |
| Jun 30, 2012 | -103.30 Mn |
| Mar 31, 2012 | -100.93 Mn |
| Dec 31, 2011 | -98.47 Mn |
| Sep 30, 2011 | -95.92 Mn |
| Jun 30, 2011 | -92.70 Mn |
| Dec 31, 2010 | -85.95 Mn |